ADT and the Mechanisms of Cardiovascular Disease- E. David Crawford

The following presentation was made at the 6th Symposium on the Treatment of Prostate Cancer (STOP-6)

E. David Crawford presents the potential mechanisms for differences in cardiovascular risk with different forms of ADT including; metabolic status, exacerbation of underlying cardiovascular disease (CVD) and preclinical data.  In addition, a discussion on the need for the risk of CVD to be assessed prior to the use of ADT. 

Additional related content: 

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.